Kilitch Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE729D01010
  • NSEID: KILITCH
  • BSEID: 524500
INR
223.70
-10.95 (-4.67%)
BSENSE

Nov 20

BSE+NSE Vol: 42.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "223.70",
    "chg": -10.95,
    "chgp": "-4.67%",
    "dir": -1,
    "prev_price": "234.65",
    "mcapval": "814.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE729D01010",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "42.44 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs Upgraded to Hold as Technicals Improve Despite Valuation Concerns",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kilitch-drugs-upgraded-to-hold-as-technicals-improve-despite-valuation-concerns-4263051",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KilitchDrugsInd_mojoScore_4263051.png",
        "date": "2026-11-16 08:01:57",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its technical outlook amid an expensive valuation and mixed financial trends. The upgrade, effective from 13 Nov 2026, is driven primarily by improved technical indicators, while valuation and financial performance present a more complex picture for investors."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kilitch-drugs-india-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-4262892",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KilitchDrugsInd_technicaldot_4262892.png",
        "date": "2026-11-16 08:00:25",
        "description": "Kilitch Drugs (India) Ltd has demonstrated a notable shift in technical momentum, with key indicators signalling a transition from a mildly bullish to a bullish trend. The stock’s recent price action, combined with positive signals from MACD, Bollinger Bands, and moving averages, suggests growing investor confidence amid a volatile pharmaceutical sector backdrop."
      },
      {
        "title": "Kilitch Drugs Valuation Shifts to Expensive Amid Strong Market Returns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-to-expensive-amid-strong-market-returns-4262851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KilitchDrugsInd_valuationdot_4262851.png",
        "date": "2026-11-16 08:00:14",
        "description": "Kilitch Drugs (India) Ltd has witnessed a notable change in its valuation parameters, shifting from a fair to an expensive rating. This development, coupled with its recent price movements and peer comparisons, invites a closer examination of its price attractiveness and investment potential within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-hold-by-marketsmojo-4262331",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KilitchDrugsInd_mojoScore_4262331.png",
        "date": "2026-11-15 10:10:41",
        "description": "Kilitch Drugs (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 November 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 November 2026, providing investors with an up-to-date perspective on the company’s standing."
      },
      {
        "title": "Kilitch Drugs Falls 3.23%: 5 Key Factors Shaping This Week’s Volatility",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kilitch-drugs-falls-323-5-key-factors-shaping-this-weeks-volatility-4256214",
        "imagepath": "",
        "date": "2026-11-08 14:00:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Technical momentum shifts to mildly bullish; valuation moves to fair</p>\n                    <p><strong>3 Nov:</strong> Mojo Grade upgraded to Hold; bullish technical momentum</p>\n                    <p><strong>4 Nov:</strong> Downgrade to Sell amid valuation and technical concerns</p>\n                    <p><strong>5 Nov:</strong> Technical momentum rebounds to bullish stance</p>\n                    <p><strong>6 Nov:</strong> Sharp 6.08% drop on heavy volume closes the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.201.00</div></di..."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Returns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-returns-4251171",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KilitchDrugsInd_technicaldot_4251171.png",
        "date": "2026-11-05 08:00:49",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a micro-cap classification and a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators reveal a complex picture of strength and caution, with key metrics such as MACD and moving averages signalling upward momentum while others like KST and Dow Theory remain inconclusive."
      },
      {
        "title": "Kilitch Drugs Downgraded to Sell Amid Valuation and Technical Concerns",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/kilitch-drugs-downgraded-to-sell-amid-valuation-and-technical-concerns-4249850",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KilitchDrugsInd_mojoScore_4249850.png",
        "date": "2026-11-04 08:02:15",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating downgraded from Hold to Sell following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. Despite some long-term growth achievements, recent quarterly results and shifting market dynamics have prompted a more cautious stance from analysts."
      },
      {
        "title": "Kilitch Drugs (India) Ltd: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-4249731",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KilitchDrugsInd_technicaldot_4249731.png",
        "date": "2026-11-04 08:00:51",
        "description": "Kilitch Drugs (India) Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early November 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with some signals pointing to sustained strength while others suggest caution for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kilitch Drugs Declines 1.23% Despite Mixed Technical Momentum and Downgrade",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/kilitch-drugs-declines-123-despite-mixed-technical-momentum-and-downgrade-4246552",
        "imagepath": "",
        "date": "2026-11-01 14:00:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens at ₹203.50, declines 2.11% amid cautious sentiment</p>\n                    <p><strong>27 Oct:</strong> Downgrade to Sell by MarketsMOJO announced; stock rebounds 4.52% to ₹208.20</p>\n                    <p><strong>28 Oct:</strong> Technical momentum upgrades to bullish; stock gains 3.05% to ₹214.55</p>\n                    <p><strong>29 Oct:</strong> Profit-taking leads to 2.73% decline to ₹208.70</p>\n                    <p><strong>30 Oct:</strong> Week closes with 3.69% drop to ₹201.00, underperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open<..."
      }
    ],
    "total": 119,
    "sid": "189669",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
      "datetime": "16-Nov-2026",
      "details": "We are submitting Scrutinizers Report for evoting of EGM",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
      "datetime": "16-Nov-2026",
      "details": "Proceeding of EGM held today i.e. 16th November 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2026",
      "details": "Newspaper Publication of Corrigendum to EGM Notice",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26",
          "dt": "2026-03-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

16-Nov-2026 | Source : BSE

We are submitting Scrutinizers Report for evoting of EGM

Shareholder Meeting / Postal Ballot-Outcome of EGM

16-Nov-2026 | Source : BSE

Proceeding of EGM held today i.e. 16th November 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

15-Nov-2026 | Source : BSE

Newspaper Publication of Corrigendum to EGM Notice

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Kilitch Drugs (India) Ltd has declared 5% dividend, ex-date: 20 Sep 19

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Kilitch Drugs (India) Ltd has announced 1:1 bonus issue, ex-date: 24 Mar 26

stock-summary
RIGHTS

Kilitch Drugs (India) Ltd has announced 2:23 rights issue, ex-date: 15 Jul 25